Diabetic Nephropathy: Advances in Pathogenesis and Novel Therapies
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 51
Special Issue Editor
Interests: diabetic nephropathy; glomerular diseases; autoimmune renal disease; hypertension; cardiovascular diseases in chronic renal disease
Special Issue Information
Dear Colleagues,
In recent years, progress has been made in our understanding of the pathogenesis of diabetic nephropathy, but it is still not well defined.
Although an increasing number of clinical trials of therapies for diabetic nephropathy are being published, there is still no available treatment. The development of personalized treatment approaches is therefore important, to offer the most appropriate therapy to each patient.
The aim of this Special Issue is to provide a comprehensive overview of the advances in pathogenesis and novel therapies in diabetic nephropathy. A better understanding of pathogenesis in diabetic nephropathy will lead to earlier diagnoses and better disease-targeted therapy. Therefore, researchers in the field of diabetic kidney disease are encouraged to submit their findings, in original articles or reviews, to this Special Issue.
Dr. Meritxell Ibernon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pathogenesis of diabetic nephropathy
- novel therapies
- risk factors for disease progression
- proteomic approach
- serologic biomarkers
- histological classification
